Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation

Europace

Volumn 12, Issue 1, 2010, Pages 24-29

  De Potter, Tom ^a   Berruezo, Antonio ^a   Mont, Lluis ^a   Matiello, Maria ^a   Tamborero, David ^a   Santibañez, Claudio ^a   Benito, Begoña ^a   Zamorano, Nibaldo ^a   Brugada, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Atrial fibrillation; Heart failure; Radiofrequency ablation

Indexed keywords

ADULT; ARTERY DIAMETER; ARTICLE; CASE CONTROL STUDY; CATHETER ABLATION; CONTROLLED STUDY; CORONARY ARTERY SPASM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PERIPHERAL BLOOD VESSEL MALFORMATION; PREDICTION; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC DYSFUNCTION; TRANSIENT ISCHEMIC ATTACK;

ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 73849137390     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup309     Document Type: Article

References (28)

1. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of a trial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666
2. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E et al. Catheter ablation for paroxysmal a trial fibrillation: segmental pulmonary vein ostial ablation versus left a trial ablation. Circulation 2003;108:2355-2360 (Pubitemid 37413542)
3. Chen MS, Marrouche NF, Khaykin Y, Gillinov AM,Wazni O, Martin DO et al. Pulmonary vein isolation for the treatment of a trial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 2004;43:1004-1009 (Pubitemid 38352980)
4. Lutomsky BA, Rostock T, Koops A, Steven D, Mullerleile K, Servatius H et al. Catheter ablation of paroxysmal a trial fibrillation improves cardiac function: a prospective study on the impact of a trial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace 2008;10:593-599
5. Berruezo A, Tamborero D, Mont L, Benito B, Tolosana JM, Sitges M et al. Preprocedural predictors of a trial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007;28:836-841
6. Cheema A, Vasamreddy CR, Dalal D, Marine JE, Dong J, Henrikson CA et al. Long-term single procedure efficacy of catheter ablation of a trial fibrillation. J Interv Card Electrophysiol 2006;15:145-155
7. Seow SC, Lim TW, Koay CH, Ross DL, Thomas SP. Efficacy and late recurrences with wide electrical pulmonary vein isolation for persistent and permanent a trial fibrillation. Europace 2007;9:1129-1133
8. Vasamreddy CR, Lickfett L, Jayam VK, Nasir K, Bradley DJ, Eldadah Z et al. Predictors of recurrence following catheter ablation of a trial fibrillation using an irrigated-tip ablation catheter. J Cardiovasc Electrophysiol 2004;15:692-697
9. De Potter T, Tavernier R, Devos D, Van Beeumen K, Duytschaever M. Predictors of success after a first circumferential pulmonary vein isolation for a trial fibrillation. J a trial Fibrillation 2009;1:311-320
10. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-2442
11. Tamborero D, Mont L, Berruezo A, Matiello M, Benito B, Sitges M et al. Left a trial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for a trial fibrillation. Circ Arrhythm Electrophysiol 2009;2: 35-40.
12. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA et al. Temporal relations of a trial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-2925
13. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. a trial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703.
14. Stevenson WG, Stevenson LW. a trial fibrillation in heart failure. N Engl J Med 1999;341:910-911
15. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with a trial fibrillation. N Engl J Med 2002;347:1825-1833
16. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T et al. A comparison of rate control and rhythm control in patients with recurrent persistent a trial fibrillation. N Engl J Med 2002;347:1834-1840
17. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL et al. Rhythm control versus rate control for a trial fibrillation and heart failure. N Engl J Med 2008; 358:2667-2677
18. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F et al. Catheter ablation for a trial fibrillation in congestive heart failure. N Engl J Med 2004;351: 2373-2383
19. Gentlesk PJ, Sauer WH, Gerstenfeld EP, Lin D, Dixit S, Zado E et al. Reversal of left ventricular dysfunction following ablation of a trial fibrillation. J Cardiovasc Electrophysiol 2007;18:9-14.
20. Tondo C, Mantica M, Russo G, Avella A, De Luca L, Pappalardo A et al. Pulmonary vein vestibule ablation for the control of a trial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol 2006; 29:962-970
21. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T et al. A new approach for catheter ablation of a trial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43:2044-2053
22. O'Neill MD, Jais P, Takahashi Y, Jonsson A, Sacher F, Hocini M et al. The stepwise ablation approach for chronic a trial fibrillation-evidence for a cumulative effect. J Interv Card Electrophysiol 2006;16:153-167
23. Jais P, O'Neill MD, Takahashi Y, Jönsson A, Hocini M, Sacher F et al. Stepwise catheter ablation of chronic a trial fibrillation: importance of discrete anatomic sites for termination. J Cardiovasc Electrophysiol 2006;17:S28-S36.
24. Stulak JM, Dearani JA, Daly RC, Zehr KJ, Sundt TM 3rd, Schaff HV. Left ventricular dysfunction in a trial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status. Ann Thorac Surg 2006;82:494-500; discussion 500-501
25. Schoonderwoerd BA, Van Gelder IC, van Veldhuisen DJ, Tieleman RG, Grandjean JG, Bel KJ et al. Electrical remodeling and a trial dilation during a trial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol 2001;12:1404-1410
26. Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for a trial fibrillation: a meta-analysis. Circulation 2000; 101:1138-1144
27. Redfearn DP, Hill JD, Keal R, Toff WD, Stafford PJ. Left ventricular dysfunction resulting from frequent unifocal ventricular ectopics with resolution following radiofrequency ablation. Europace 2003;5:247-250
28. Sekiguchi Y, Aonuma K, Yamauchi Y, Obayashi T, Niwa A, Hachiya H et al. Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats. J Cardiovasc Electrophysiol 2005;16: 1057-1063